PL1727562T3 - Sposób szczepienia przeciw zakażeniu jąder wirusem BVD - Google Patents

Sposób szczepienia przeciw zakażeniu jąder wirusem BVD

Info

Publication number: PL1727562T3
Authority: PL; Poland
Prior art keywords: vaccination against; bvdv infection; against testicular; testicular bvdv; infection
Prior art date: 2004-03-17

Application number

PL05708706T

Other languages

English (en)

Inventor

Michael Aaron Ellsworth

Cassius Mcallister Tucker

Original Assignee

Pharmacia & Upjohn Co Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-17

Filing date

2005-03-04

Publication date

2008-10-31

2005-03-04 Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc

2008-10-31 Publication of PL1727562T3 publication Critical patent/PL1727562T3/pl

Links

PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
238000000034 method Methods 0.000 title 1
230000002381 testicular Effects 0.000 title 1
238000002255 vaccination Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL05708706T 2004-03-17 2005-03-04 Sposób szczepienia przeciw zakażeniu jąder wirusem BVD PL1727562T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US55386704P	2004-03-17	2004-03-17
EP05708706A EP1727562B1 (en)	2004-03-17	2005-03-04	Method of vaccination against testicular bvdv infection
PCT/IB2005/000610 WO2005089793A1 (en)	2004-03-17	2005-03-04	Method of vaccination against testicular bvdv infection

Publications (1)

Publication Number	Publication Date
PL1727562T3 true PL1727562T3 (pl)	2008-10-31

Family

ID=34961163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05708706T PL1727562T3 (pl)	2004-03-17	2005-03-04	Sposób szczepienia przeciw zakażeniu jąder wirusem BVD

Country Status (23)

Country	Link
US (1)	US20080260778A1 (pl)
EP (1)	EP1727562B1 (pl)
JP (1)	JP4105220B2 (pl)
KR (2)	KR20080036160A (pl)
CN (1)	CN1929859A (pl)
AR (1)	AR048671A1 (pl)
AT (1)	ATE398462T1 (pl)
AU (1)	AU2005224179B2 (pl)
BR (1)	BRPI0508941A (pl)
CA (1)	CA2560532A1 (pl)
DE (1)	DE602005007584D1 (pl)
DK (1)	DK1727562T3 (pl)
ES (1)	ES2306101T3 (pl)
NO (1)	NO20063603L (pl)
NZ (1)	NZ549592A (pl)
PL (1)	PL1727562T3 (pl)
PT (1)	PT1727562E (pl)
RU (1)	RU2335298C2 (pl)
SI (1)	SI1727562T1 (pl)
TW (1)	TWI306404B (pl)
UA (1)	UA86405C2 (pl)
WO (1)	WO2005089793A1 (pl)
ZA (1)	ZA200607132B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090068223A1 (en) *	2005-11-15	2009-03-12	Boehringer Ingelheim Vetmedica, Inc.	Combination vaccine comprising an attenuated bovine viral diarrhea virus
MX347911B (es) *	2010-09-21	2017-05-17	Intervet Int Bv	Vacuna contra virus de diarrea viral de bovinos.
AR084358A1 (es)	2010-12-27	2013-05-08	Lilly Co Eli	Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
WO2012092053A1 (en) *	2010-12-27	2012-07-05	Eli Lilly And Company	Bovine viral diarrhea virus type 1b vaccine compositions and methods
US9480739B2 (en) *	2013-03-15	2016-11-01	Intervet Inc.	Bovine virus vaccines that are liquid stable
CN107823639B (zh) *	2017-11-10	2020-10-02	齐鲁动物保健品有限公司	牛病毒性腹泻病毒灭活疫苗及其制备方法
WO2025172363A1 (en) *	2024-02-12	2025-08-21	Hipra Scientific, S.L.U.	Vaccine against bovine viral diarrohea virus and bovine respiratory disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5593873A (en) *	1986-01-27	1997-01-14	Syntro Corporation	Recombinant infectious bovine rhinotracheitis virus
US5709865A (en) *	1994-11-10	1998-01-20	Biostar Inc.	Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) *	1996-05-24	1999-12-14	Board Of Regents Of University Of Nebraska	Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6174667B1 (en) *	1997-09-23	2001-01-16	Cornell Research Foundation, Inc.	Bovine viral diarrhea virus serum antigen capture
US6606457B2 (en) *	2001-06-19	2003-08-12	Pentax Corporation	Focused image tremble correcting device
ATE354681T1 (de) *	2001-08-09	2007-03-15	Idexx Lab Inc	Nachweis des virus der viralen rinderdiarrhoe in gewebsproben

2005
- 2005-03-04 PL PL05708706T patent/PL1727562T3/pl unknown
- 2005-03-04 CN CNA2005800082710A patent/CN1929859A/zh active Pending
- 2005-03-04 KR KR1020087008843A patent/KR20080036160A/ko not_active Withdrawn
- 2005-03-04 SI SI200530316T patent/SI1727562T1/sl unknown
- 2005-03-04 RU RU2006133328/13A patent/RU2335298C2/ru active
- 2005-03-04 DK DK05708706T patent/DK1727562T3/da active
- 2005-03-04 BR BRPI0508941-7A patent/BRPI0508941A/pt not_active IP Right Cessation
- 2005-03-04 CA CA002560532A patent/CA2560532A1/en not_active Abandoned
- 2005-03-04 ES ES05708706T patent/ES2306101T3/es not_active Expired - Lifetime
- 2005-03-04 KR KR1020067019032A patent/KR20060127199A/ko not_active Ceased
- 2005-03-04 NZ NZ549592A patent/NZ549592A/en unknown
- 2005-03-04 AU AU2005224179A patent/AU2005224179B2/en not_active Ceased
- 2005-03-04 UA UAA200609917A patent/UA86405C2/ru unknown
- 2005-03-04 PT PT05708706T patent/PT1727562E/pt unknown
- 2005-03-04 EP EP05708706A patent/EP1727562B1/en not_active Expired - Lifetime
- 2005-03-04 WO PCT/IB2005/000610 patent/WO2005089793A1/en not_active Ceased
- 2005-03-04 US US10/593,134 patent/US20080260778A1/en not_active Abandoned
- 2005-03-04 DE DE602005007584T patent/DE602005007584D1/de not_active Expired - Fee Related
- 2005-03-04 AT AT05708706T patent/ATE398462T1/de not_active IP Right Cessation
- 2005-03-04 JP JP2007503432A patent/JP4105220B2/ja not_active Expired - Fee Related
- 2005-03-15 AR ARP050100998A patent/AR048671A1/es unknown
- 2005-03-16 TW TW094108014A patent/TWI306404B/zh active
2006
- 2006-08-09 NO NO20063603A patent/NO20063603L/no not_active Application Discontinuation
- 2006-08-25 ZA ZA200607132A patent/ZA200607132B/xx unknown

Also Published As

Publication number	Publication date
RU2335298C2 (ru)	2008-10-10
UA86405C2 (ru)	2009-04-27
ATE398462T1 (de)	2008-07-15
DK1727562T3 (da)	2008-09-15
TWI306404B (en)	2009-02-21
ZA200607132B (en)	2008-08-27
ES2306101T3 (es)	2008-11-01
KR20080036160A (ko)	2008-04-24
CN1929859A (zh)	2007-03-14
US20080260778A1 (en)	2008-10-23
AU2005224179A1 (en)	2005-09-29
BRPI0508941A (pt)	2007-08-14
SI1727562T1 (sl)	2008-10-31
EP1727562A1 (en)	2006-12-06
EP1727562B1 (en)	2008-06-18
AR048671A1 (es)	2006-05-17
AU2005224179B2 (en)	2007-08-23
PT1727562E (pt)	2008-09-05
WO2005089793A1 (en)	2005-09-29
KR20060127199A (ko)	2006-12-11
TW200531701A (en)	2005-10-01
DE602005007584D1 (de)	2008-07-31
JP4105220B2 (ja)	2008-06-25
CA2560532A1 (en)	2005-09-29
NZ549592A (en)	2008-12-24
RU2006133328A (ru)	2008-03-27
JP2007529498A (ja)	2007-10-25
NO20063603L (no)	2006-09-08

Publication	Publication Date	Title
GB0325192D0 (en)	2003-12-03	Method of use
ZA200704909B (en)	2012-12-27	Method of treatment or prophylaxis
TWI347184B (en)	2011-08-21	Methods of treating hiv infection
EP1656088A4 (en)	2010-07-28	METHODS FOR REDUCING THE RISK OF INFECTION DUE TO PATHOGENS
IL182993A0 (en)	2007-09-20	Treatment of mastitis
GB0422439D0 (en)	2004-11-10	Inhibitors of infection
ZA200607132B (en)	2008-08-27	Method of vaccination against testicular BVDV infection
EP1585536A4 (en)	2009-08-05	METHOD FOR TREATING DISORDERS BY ADMINISTERING STREPTOLYSIN O
GB0302572D0 (en)	2003-03-12	Method of treatment
ZA200607115B (en)	2007-09-26	Permanent treatment method
GB0306309D0 (en)	2003-04-23	Method of treatment
EP1964538A4 (en)	2013-04-10	PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
EP1827475A4 (en)	2009-08-12	METHOD FOR TREATING HIV INFECTION
GB0426196D0 (en)	2004-12-29	Methods of treatment
MY144154A (en)	2011-08-15	Method of combating infection
GB0327975D0 (en)	2004-01-07	Methods of treatment
PL1721965T3 (pl)	2012-04-30	Sposób wytwarzania i zastosowanie kultur pierwotniaków
GB0501129D0 (en)	2005-02-23	Method of treatment by administration of RNA
GB0415160D0 (en)	2004-08-11	Inhibitors of bacterial infection
GB0400633D0 (en)	2004-02-11	Method of vaccine preparation
GB0500932D0 (en)	2005-02-23	Method of vaccine preparation
GB0402389D0 (en)	2004-03-10	Method of cryopreservation
GB0300455D0 (en)	2003-02-12	Meyhod of vaccine preparation
GB0422012D0 (en)	2004-11-03	Methods of treatment
GB0322921D0 (en)	2003-11-05	Methods of treatment